FR2663336B1
(fr)
|
1990-06-18 |
1992-09-04 |
Adir |
Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
CZ220498A3
(cs)
|
1996-01-17 |
1998-11-11 |
Novo Nordisk A/S |
Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
|
DE69737479T4
(de)
|
1996-08-30 |
2010-05-06 |
Novo Nordisk A/S |
Glp-1 derivate
|
RU2200161C2
(ru)
|
1996-12-31 |
2003-03-10 |
Др. Редди'З Рисерч Фаундейшн |
Новые производные азолидиндиона, способ их получения (варианты), фармацевтические композиции на их основе, способ предупреждения или лечения, способ снижения глюкозы и промежуточное соединение
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
KR20010021936A
(ko)
|
1997-07-16 |
2001-03-15 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용
|
CO4970713A1
(es)
|
1997-09-19 |
2000-11-07 |
Sanofi Synthelabo |
Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
|
SK13412000A3
(sk)
|
1998-03-12 |
2001-04-09 |
Teijin Limited |
Deriváty benzofuryl-alfa-pyrónu, farmaceutické prostriedky, synergisty, inhibítory a činidlá
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
EP2322545A1
(en)
|
1998-12-07 |
2011-05-18 |
Ipsen Pharma |
Analogues of GLP-1
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
US6608185B1
(en)
|
1999-03-25 |
2003-08-19 |
Kitasato Institute |
Substances KF-1040T4A,KF-1040T4B, KF-1040T5A, and KF-1040T5B, and process for producing same
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
WO2000063208A1
(en)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
AU3957600A
(en)
|
1999-04-26 |
2000-11-10 |
Boehringer Ingelheim International Gmbh |
Piperidyl-imidazole derivatives, their preparations and therapeutic uses
|
US6284766B1
(en)
|
1999-04-30 |
2001-09-04 |
Neurogen Corporation |
9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands
|
GB9911863D0
(en)
|
1999-05-21 |
1999-07-21 |
Knoll Ag |
Therapeutic agents
|
ES2223536T3
(es)
|
1999-06-15 |
2005-03-01 |
Bristol-Myers Squibb Pharma Company |
Gamma-carbolinas condensadas con heterociclos sustituidas.
|
EP1194425B1
(de)
|
1999-06-23 |
2005-08-10 |
Aventis Pharma Deutschland GmbH |
Substituierte benzimidazole
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
EP1204654B1
(en)
|
1999-07-29 |
2003-07-23 |
Eli Lilly And Company |
Benzofurylpiperazines: 5-ht2c serotonin receptor agonists
|
FR2796945B1
(fr)
*
|
1999-07-30 |
2002-06-28 |
Sod Conseils Rech Applic |
Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
|
CA2383781A1
(en)
|
1999-09-01 |
2001-03-08 |
Aventis Pharma Deutschland Gmbh |
Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
|
EP1214060A2
(en)
|
1999-09-10 |
2002-06-19 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
JP2003509429A
(ja)
|
1999-09-10 |
2003-03-11 |
ノボ ノルディスク アクティーゼルスカブ |
タンパク質チロシンホスファターゼ(ptpアーゼ)のモジュレーター
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
SI1268435T1
(sl)
|
2000-03-23 |
2007-02-28 |
Solvay Pharm Bv |
4,5-dihidro-1h-pirazolni derivati s cb 1-antagonisticno aktivnostjo
|
IL151376A0
(en)
|
2000-03-31 |
2003-04-10 |
Pfizer Prod Inc |
Malonamic acids and derivatives thereof as thyroid receptor ligands
|
DK1277736T3
(da)
|
2000-04-28 |
2007-10-01 |
Asahi Kasei Pharma Corp |
Hidtil ukendte bicykliske forbindelser
|
EP1288202A4
(en)
|
2000-05-11 |
2003-07-02 |
Banyu Pharma Co Ltd |
N-ACYLTETRAHYDROISOQUINOLINE DERIVATIVES
|
JP2004507456A
(ja)
|
2000-05-11 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
成長ホルモン分泌促進薬として有用なテトラヒドロイソキノリン類縁体
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
CA2410597A1
(en)
|
2000-05-30 |
2001-12-06 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
US6395784B1
(en)
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
DE60110066T2
(de)
|
2000-06-16 |
2006-02-02 |
Smithkline Beecham P.L.C., Brentford |
Piperidine zur verwendung als orexinrezeptorantagonisten
|
JP2004504303A
(ja)
|
2000-07-05 |
2004-02-12 |
シナプティック・ファーマスーティカル・コーポレーション |
選択的メラニン凝集ホルモン−1(mch1)受容体アンタゴニストおよびその使用
|
JP2004502423A
(ja)
|
2000-07-05 |
2004-01-29 |
シナプティック・ファーマスーティカル・コーポレーション |
ヒトメラニン濃縮ホルモン受容体(mch1)をコードするdna及びその使用
|
WO2002042304A2
(en)
|
2000-11-03 |
2002-05-30 |
Wyeth |
Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists
|
ATE329901T1
(de)
|
2000-11-10 |
2006-07-15 |
Lilly Co Eli |
3-substituierte oxindolderivate als beta-3- agonisten
|
HUP0004741A2
(hu)
|
2000-11-28 |
2002-12-28 |
Sanofi-Synthelabo |
Kémiai eljárás tiazolszármazékok előállítására és új intermedier
|
CZ20031733A3
(cs)
|
2000-12-21 |
2003-09-17 |
Aventis Pharma Deutschland Gmbh |
Difenylazetidinonové deriváty a farmaceutické prostředky s jejich obsahem
|
EP1345922B1
(en)
|
2000-12-21 |
2006-05-31 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
IL156550A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
CN100366614C
(zh)
|
2001-03-22 |
2008-02-06 |
索尔瓦药物有限公司 |
具有cb1-拮抗活性的4,5-二氢-1h-吡唑衍生物
|
ES2319619T3
(es)
|
2001-05-04 |
2009-05-11 |
Amgen Inc. |
Compuestos heterociclicos condensados.
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
EP1736567B1
(en)
|
2001-06-28 |
2010-04-07 |
Alonim Holding Agricultural Cooperative Society Ltd. |
Treatment for improved magnesium surface corrosion-resistance
|
MXPA03011886A
(es)
|
2001-07-05 |
2005-03-07 |
Lundbeck & Co As H |
Piperidinias anilinicas sustituidas como antagonistas selectivos de mch.
|
WO2003007887A2
(en)
|
2001-07-20 |
2003-01-30 |
Merck & Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
AU2002331064B2
(en)
|
2001-08-10 |
2007-08-23 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10142734A1
(de)
|
2001-08-31 |
2003-03-27 |
Aventis Pharma Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2007036945A2
(en)
|
2005-09-30 |
2007-04-05 |
Compugen Ltd. |
Hepatocyte growth factor receptor splice variants and methods of using same
|
BR0212044A
(pt)
|
2001-09-21 |
2004-08-17 |
Solvay Pharm Bv |
Compostos, composições farmacêuticas, método de preparação das mesmas, e, uso de um composto
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
JP2005532982A
(ja)
|
2001-09-24 |
2005-11-04 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのピロール誘導体の製造及び使用
|
HN2002000266A
(es)
|
2001-09-24 |
2003-11-16 |
Bayer Corp |
Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad.
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
AU2002353718B2
(en)
|
2001-11-22 |
2007-05-10 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
WO2003044000A1
(en)
|
2001-11-22 |
2003-05-30 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
EP1461333A1
(en)
|
2001-11-22 |
2004-09-29 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
GB0202015D0
(en)
|
2002-01-29 |
2002-03-13 |
Hoffmann La Roche |
Piperazine Derivatives
|
DE60317631T2
(de)
|
2002-02-01 |
2008-09-25 |
Merck & Co., Inc. |
11-beta-hydroxysteroid-dehydrogenase-1-hemmer zur behandlung von diabetes, adipositas und dyslipidämie
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
CN1642599A
(zh)
|
2002-02-27 |
2005-07-20 |
辉瑞产品公司 |
Acc抑制剂
|
PT1483265E
(pt)
|
2002-03-05 |
2007-01-31 |
Lilly Co Eli |
Derivados de purina como inibidores de quinase
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
CA2480856A1
(en)
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Substituted aryl amides
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
GB0208384D0
(en)
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
JP4459629B2
(ja)
|
2002-04-12 |
2010-04-28 |
メルク エンド カムパニー インコーポレーテッド |
二環式アミド
|
JPWO2003097064A1
(ja)
|
2002-05-17 |
2005-09-15 |
協和醗酵工業株式会社 |
糖尿病治療剤
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
WO2004005324A2
(en)
|
2002-07-09 |
2004-01-15 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
CN100513404C
(zh)
|
2002-07-09 |
2009-07-15 |
法斯根公司 |
新化合物、含该化合物的药物组合物以及该化合物的应用方法
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
EP1523475B1
(de)
|
2002-07-12 |
2009-12-23 |
Sanofi-Aventis Deutschland GmbH |
Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE10233817A1
(de)
|
2002-07-25 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
IL150914A
(en)
|
2002-07-25 |
2014-04-30 |
Zamir Tribelsky |
A method for hydro-optronio photochemical treatment of liquids
|
JP2005533858A
(ja)
|
2002-07-27 |
2005-11-10 |
アストラゼネカ アクチボラグ |
化合物
|
AU2003250117B2
(en)
|
2002-07-29 |
2007-05-10 |
F. Hoffmann-La Roche Ag |
Novel benzodioxoles
|
KR20050069977A
(ko)
|
2002-08-07 |
2005-07-05 |
미쯔비시 웰 파마 가부시키가이샤 |
디히드로피라졸로피리딘 화합물
|
GB0219022D0
(en)
|
2002-08-15 |
2002-09-25 |
Karobio Ab |
Novel thyromimetic compounds
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
EP1537087B1
(fr)
|
2002-09-05 |
2012-11-28 |
Aventis Pharma S.A. |
Derives de 3-aminoindazole comme inhibiteurs de kinase et compositions pharmaceutiques les renfermant
|
CA2498272A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
CA2499497A1
(en)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Substituted pyrimidines
|
AU2003269242A1
(en)
|
2002-10-11 |
2004-05-04 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
|
DE60320008T2
(de)
|
2002-10-18 |
2009-06-18 |
Merck & Co., Inc. |
Heterozyklische beta-aminoverbindungen als inhibitoren des dipeptidylpeptidase zur behandlung bzw. prevention von diabetes
|
WO2004035566A1
(en)
|
2002-10-18 |
2004-04-29 |
Pfizer Products Inc. |
Cannabinoid receptor ligands and uses thereof
|
TW200504033A
(en)
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
EP1556040A1
(en)
|
2002-10-24 |
2005-07-27 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
AU2003291342A1
(en)
|
2002-11-05 |
2004-06-07 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
JP2006514102A
(ja)
|
2002-11-07 |
2006-04-27 |
アストラゼネカ アクチボラグ |
2−オキソ−エタンスルホンアミド誘導体
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
KR20050088194A
(ko)
|
2002-12-19 |
2005-09-02 |
머크 앤드 캄파니 인코포레이티드 |
치환된 아미드
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
CA2509086C
(en)
|
2003-01-06 |
2012-08-21 |
Eli Lilly And Company |
Substituted arylcyclopropylacetamides as glucokinase activators
|
RS20050532A
(en)
|
2003-01-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
US7262196B2
(en)
|
2003-02-11 |
2007-08-28 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
JP2006517551A
(ja)
|
2003-02-13 |
2006-07-27 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
窒素置換ヘキサヒドロピラジノ[1,2−a]ピリミジン−4,7−ジオン誘導体、その製造方法および医薬としてのその使用
|
ATE472548T1
(de)
|
2003-02-13 |
2010-07-15 |
Sanofi Aventis Deutschland |
Substituierte hexahydro-pyrazino(1,2-a)pyrimidin- 4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
AU2004213124A1
(en)
|
2003-02-19 |
2004-09-02 |
F. Hoffmann-La Roche Ag |
Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors
|
US7160886B2
(en)
|
2003-03-03 |
2007-01-09 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
EP1460069A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
EP1460075A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
|
EP1611104B1
(en)
|
2003-03-26 |
2009-07-01 |
Actelion Pharmaceuticals Ltd. |
Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
|
EP1610789B1
(en)
|
2003-03-26 |
2010-07-21 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
DE10314610A1
(de)
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
ATE455547T1
(de)
|
2003-04-11 |
2010-02-15 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1, 2,4-triazolen
|
JP2006522745A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
置換1,2,4−トリアゾールの薬学的使用
|
MXPA05010859A
(es)
|
2003-04-11 |
2005-12-14 |
Smithkline Beecham Corp |
Antagonistas mchr1 heterociclicos.
|
ATE482747T1
(de)
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
US20060200534A1
(en)
|
2003-04-25 |
2006-09-07 |
Takahiro Nagai |
Multi-medium information sharing system
|
ATE398449T1
(de)
|
2003-05-01 |
2008-07-15 |
Vernalis Res Ltd |
Verwendung von azetidincarboxamidderivaten in therapie
|
WO2004096794A1
(en)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
|
KR20060010770A
(ko)
|
2003-05-01 |
2006-02-02 |
베르날리스 리서치 리미티드 |
아제티딘카르복스아미드 유도체와 씨비1 수용체로 매개된질병의 치료에 대한 이들의 용도
|
WO2004099157A1
(en)
|
2003-05-07 |
2004-11-18 |
Pfizer Products Inc. |
Cannabinoid receptor ligands and uses thereof
|
CN1784226A
(zh)
|
2003-05-09 |
2006-06-07 |
麦克公司 |
苯并咪唑化合物、含有苯并咪唑化合物的组合物以及使用方法
|
AR044152A1
(es)
|
2003-05-09 |
2005-08-24 |
Bayer Corp |
Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
WO2004103980A1
(en)
|
2003-05-21 |
2004-12-02 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
|
JP2007501861A
(ja)
|
2003-05-23 |
2007-02-01 |
カイロン コーポレイション |
Mc4−rアゴニストとしてのグアニジノ置換キナゾリノン化合物
|
AU2004243301B2
(en)
|
2003-05-29 |
2010-03-25 |
Merck Sharp & Dohme Corp. |
Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
RU2006100298A
(ru)
|
2003-06-11 |
2006-05-10 |
Мерк энд Ко., Инк. (US) |
Замещенные производные 3-алкил-и 3-алкенилазетидинов
|
JP2007500748A
(ja)
|
2003-06-13 |
2007-01-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤としての置換インダゾリル(インドリル)マレイミド誘導体
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
CA2527033A1
(en)
|
2003-06-18 |
2004-12-23 |
Astrazeneca Ab |
2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
|
EP1644023A2
(en)
|
2003-06-19 |
2006-04-12 |
Eli Lilly And Company |
Melanocortin recptor 4(mc4) agonists and their uses
|
MXPA05013733A
(es)
|
2003-06-20 |
2006-03-08 |
Hoffmann La Roche |
2-aminobenzotiazoles como agonistas inversos del receptor de cb1.
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
WO2004113310A1
(en)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
US7029524B2
(en)
|
2003-06-27 |
2006-04-18 |
Day-Glo Color Corp. |
Water-based spray marking composition
|
WO2005001921A1
(ja)
|
2003-06-27 |
2005-01-06 |
Nec Corporation |
薄膜トランジスタ、薄膜トランジスタ基板、電子機器及び多結晶半導体薄膜の製造方法
|
JP2007525470A
(ja)
|
2003-07-09 |
2007-09-06 |
フォーブス メディ−テック インコーポレーテッド |
ステロール及び/又はスタノール及びコレステロール生合成阻害剤を含む新規化合物及び組成物、並びに様々な疾患及び症状の治療又は防止へのそれらの使用
|
DE10331074A1
(de)
|
2003-07-09 |
2005-02-03 |
Conti Temic Microelectronic Gmbh |
Sensoranordnung zur Abstands- und/oder Geschwindigkeitsmessung
|
WO2005007628A1
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
CA2532808A1
(en)
|
2003-07-22 |
2005-02-03 |
Merck & Co., Inc. |
Piperidine derivatives as melanocortin-4 receptor agonists
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
EP1653949A4
(en)
|
2003-08-07 |
2009-04-22 |
Merck & Co Inc |
PYRAZOL CARBOXAMIDE AS AN INHIBITOR OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1
|
WO2005013907A2
(en)
|
2003-08-07 |
2005-02-17 |
Japan Tobacco Inc. |
Pyrrolo[1,2-b]pyridazine derivatives
|
TW200510324A
(en)
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
JP2007502283A
(ja)
|
2003-08-13 |
2007-02-08 |
アムジェン インコーポレイテッド |
メラニン凝集ホルモン受容体アンタゴニスト
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
EP1660456A2
(en)
|
2003-08-25 |
2006-05-31 |
Microbia Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
US20070161577A1
(en)
|
2003-08-28 |
2007-07-12 |
Martinez Eduardo J |
Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones
|
CN1956949A
(zh)
|
2003-09-18 |
2007-05-02 |
默克公司 |
取代的磺酰胺
|
CA2539253A1
(en)
|
2003-09-19 |
2005-03-31 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
SA04250288B1
(ar)
|
2003-09-19 |
2008-07-19 |
سولفاي فارماسوتيكالز بي . في |
مشتقات ثيازول thiazole كمعدلات لمستقبل المكونات الكيميائية للقنب cannabinoid
|
US20050070712A1
(en)
|
2003-09-26 |
2005-03-31 |
Christi Kosogof |
Pyrimidine derivatives as ghrelin receptor modulators
|
CN100482682C
(zh)
|
2003-09-30 |
2009-04-29 |
诺沃挪第克公司 |
黑皮素受体激动剂
|
US7244843B2
(en)
|
2003-10-07 |
2007-07-17 |
Bristol-Myers Squibb Company |
Modulators of serotonin receptors
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
US20050119252A1
(en)
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
GB0325192D0
(en)
|
2003-10-29 |
2003-12-03 |
Astrazeneca Ab |
Method of use
|
CA2543943A1
(en)
|
2003-10-30 |
2005-05-19 |
Merck & Co., Inc. |
2-azetidinones as anti-hypercholesterolemic agents
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
WO2005042692A2
(en)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
|
KR100794856B1
(ko)
|
2003-11-07 |
2008-01-14 |
에프. 호프만-라 로슈 아게 |
벤조[b][1,4]다이옥세핀 유도체
|
PT1682499E
(pt)
|
2003-11-10 |
2007-11-05 |
Microbia Inc |
4-biarilil-1-fenilazetidin-2-onas
|
KR20050045927A
(ko)
|
2003-11-12 |
2005-05-17 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
WO2005047251A1
(en)
|
2003-11-12 |
2005-05-26 |
Lg Life Sciences Ltd. |
Melanocortin receptor agonists
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
AU2004293012A1
(en)
|
2003-11-19 |
2005-06-09 |
Rustum S. Boyce |
Quinazolinone compounds with reduced bioaccumulation
|
EP1538159A1
(en)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
WO2005060985A1
(en)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
EP1557417B1
(en)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
|
TW200530246A
(en)
|
2003-12-19 |
2005-09-16 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
CA2545506A1
(en)
|
2003-12-19 |
2005-06-30 |
Biovitrum Ab |
Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
|
WO2005065680A1
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Cyclic guanidines, compositions containing such compounds and methods of use
|
ES2282927T3
(es)
|
2003-12-19 |
2007-10-16 |
Bristol-Myers Squibb Company |
Heterociclos azabiciclicos como moduladores de receptores canabinoides.
|
WO2005062824A2
(en)
|
2003-12-23 |
2005-07-14 |
Merck & Co., Inc. |
Anti-hypercholesterolemic compounds
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
SA04250427A
(ar)
|
2003-12-23 |
2005-12-03 |
استرازينيكا ايه بي |
مشتقات ثاني فينيل أزيتيدون
|
NZ547965A
(en)
|
2003-12-24 |
2009-12-24 |
Prosidion Ltd |
1,2,4-Oxadiazole derivatives as GPCR receptor agonists
|
WO2005067932A1
(en)
|
2004-01-06 |
2005-07-28 |
Janssen Pharmaceutica, N.V. |
(3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
|
JP2005206492A
(ja)
|
2004-01-21 |
2005-08-04 |
Sankyo Co Ltd |
スルホンアミド化合物
|
DE102004003812A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004003811A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
ES2349195T3
(es)
|
2004-01-28 |
2010-12-28 |
F. Hoffmann-La Roche Ag |
Espiro-benzodioxoles y su uso como antagonistas de cb1.
|
JP2007519605A
(ja)
|
2004-01-30 |
2007-07-19 |
日本たばこ産業株式会社 |
食欲抑制薬
|
ATE438645T1
(de)
|
2004-01-31 |
2009-08-15 |
Sanofi Aventis Deutschland |
7-phenylamino-4-chinolon-3-carbonsäure-derivate verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
WO2005077897A1
(en)
|
2004-02-17 |
2005-08-25 |
Laboratorios Del Dr. Esteve S.A. |
Substituted azetidine compounds, their preparation and use as medicaments
|
JP2007523905A
(ja)
|
2004-02-18 |
2007-08-23 |
アストラゼネカ アクチボラグ |
化合物
|
SI1725536T1
(sl)
|
2004-02-19 |
2009-04-30 |
Solvay Pharm Bv |
Derivati imidazolina s cb1-antagonistiäśno aktivnostjo
|
US20090149463A1
(en)
|
2004-02-20 |
2009-06-11 |
Leifeng Cheng |
Therapeutic agents
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
WO2005080424A2
(en)
|
2004-02-23 |
2005-09-01 |
Rheoscience A/S |
Peptide yy analogues
|
CN102329267A
(zh)
|
2004-02-25 |
2012-01-25 |
伊莱利利公司 |
作为5-HT2C受体激动剂的6-取代的2,3,4,5-四氢-1H-苯并[d]氮杂䓬
|
WO2005082893A2
(en)
|
2004-02-25 |
2005-09-09 |
Eli Lilly And Company |
Histamine h3 receptor antagonists, preparation and therapeutic uses
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
ZA200608028B
(en)
|
2004-03-04 |
2009-03-25 |
Kissei Pharmaceutical |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
CN1930126A
(zh)
|
2004-03-05 |
2007-03-14 |
万有制药株式会社 |
吡啶酮衍生物
|
WO2005085226A1
(en)
|
2004-03-10 |
2005-09-15 |
Janssen Pharmaceutica N.V. |
Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
GB0406378D0
(en)
|
2004-03-22 |
2004-04-21 |
Karobio Ab |
Novel pharmaceutical compositions
|
CN1938286A
(zh)
|
2004-03-29 |
2007-03-28 |
默克公司 |
作为11-β-羟甾类脱氢酶-1抑制剂的二芳基三唑
|
EP1586318A1
(en)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiadiazolidinones as GSK-3 inhibitors
|
EP1732566A4
(en)
|
2004-04-05 |
2010-01-13 |
Takeda Pharmaceutical |
6-azaindole COMPOUND
|
US20080096922A1
(en)
|
2004-04-06 |
2008-04-24 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel Sulfonamide derivative
|
JP2007532511A
(ja)
|
2004-04-09 |
2007-11-15 |
スミスクライン ビーチャム コーポレーション |
低用量医薬品
|
FR2868780B1
(fr)
|
2004-04-13 |
2008-10-17 |
Sanofi Synthelabo |
Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique
|
JPWO2005108370A1
(ja)
|
2004-04-16 |
2008-03-21 |
味の素株式会社 |
ベンゼン化合物
|
GEP20094723B
(en)
|
2004-05-25 |
2009-07-10 |
Pfizer Prod Inc |
Tetraazabenzo [e] azulene derivatives and analogs thereof
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
EP1773780A4
(en)
|
2004-06-24 |
2008-01-09 |
Incyte Corp |
AMIDO COMPOUNDS AND USES THEREOF AS PHARMACEUTICAL PRODUCTS
|
AU2005257303A1
(en)
|
2004-06-24 |
2006-01-05 |
Shionogi & Co., Ltd. |
Sulfonamide compound
|
MXPA06014573A
(es)
|
2004-06-24 |
2007-03-12 |
Incyte Corp |
Compuestos amido y su uso como farmaceuticos.
|
CA2570688A1
(en)
|
2004-06-24 |
2006-02-02 |
Eli Lilly And Company |
Compounds and methods for treating dyslipidemia
|
TW200606137A
(en)
|
2004-07-02 |
2006-02-16 |
Sankyo Co |
Urea derivatives
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
GB0416728D0
(en)
|
2004-07-27 |
2004-09-01 |
7Tm Pharma As |
Medicinal use of receptor ligands
|
DE602005008079D1
(de)
|
2004-07-28 |
2008-08-21 |
Hoffmann La Roche |
Aryl-pyridinderivate als 11-beta-hsd1-hemmer
|
FR2873690B1
(fr)
|
2004-07-29 |
2006-10-13 |
Sanofi Synthelabo |
Derives d'oxopiperidine, leur preparation et leur application en therapeutique
|
DE602005022089D1
(de)
|
2004-08-06 |
2010-08-12 |
Merck Sharp & Dohme |
Sulfonylverbindungen als hemmer von 11-beta-hydroxysteroiddehydrogenase-1
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
CA2576407A1
(en)
|
2004-08-12 |
2006-02-16 |
Prosidion Limited |
Substituted phenylacetamides and their use as glucokinase activators
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006019020A1
(ja)
|
2004-08-16 |
2006-02-23 |
Sankyo Company, Limited |
置換されたウレア化合物
|
US20070225259A1
(en)
|
2004-08-18 |
2007-09-27 |
Qun Dang |
Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase
|
ATE452631T1
(de)
|
2004-08-30 |
2010-01-15 |
Janssen Pharmaceutica Nv |
N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer
|
AU2005284485A1
(en)
|
2004-09-11 |
2006-03-23 |
Sanofi-Aventis Deutschland Gmbh |
7-azaindoles and their use as PPAR agonists
|
PT1797042E
(pt)
|
2004-09-29 |
2009-02-12 |
Hoffmann La Roche |
Derivados de indozolona como inibidores de 11b-hsd1
|
MX2007003785A
(es)
|
2004-09-29 |
2007-07-12 |
Kissei Pharmaceutical |
Compuesto heterociclico nitrogenoso 1-(b-d-glicopiranosil)-3, composicion medicinal que contiene el mismo, y uso medicinal del mismo.
|
CN101065356A
(zh)
|
2004-10-01 |
2007-10-31 |
万有制药株式会社 |
2-芳基甲酰胺-含氮杂环化合物
|
ATE481969T1
(de)
|
2004-10-01 |
2010-10-15 |
Merck Sharp & Dohme |
Aminopiperidine als dipeptidylpeptidase-iv- inhibitoren zur behandlung oder prävention von diabetes
|
JP2008515856A
(ja)
|
2004-10-07 |
2008-05-15 |
ノボ ノルディスク アクティーゼルスカブ |
遅延性glp−1化合物
|
WO2006037811A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
CN101076524A
(zh)
|
2004-10-12 |
2007-11-21 |
法马科皮亚药物研发公司 |
作为选择性黑色素浓集激素受体拮抗剂的治疗肥胖和相关病症的双环化合物
|
US8138342B2
(en)
|
2004-10-12 |
2012-03-20 |
High Point Pharmacueticals, LLC |
11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
EP1809626A2
(en)
|
2004-10-13 |
2007-07-25 |
Neurogen Corporation |
Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
WO2006045565A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
DK1807072T3
(da)
|
2004-10-29 |
2009-03-16 |
Lilly Co Eli |
Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1
|
EP1812407A2
(en)
|
2004-11-02 |
2007-08-01 |
Pfizer, Inc. |
Novel compounds of substituted and unsubstituted adamantyl amides
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
WO2006051662A1
(ja)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
チアゾール誘導体
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
CA2587800C
(en)
|
2004-11-29 |
2012-06-12 |
Merck & Co., Inc. |
Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
AU2006283062B2
(en)
|
2005-08-26 |
2011-04-14 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
WO2006059744A1
(ja)
|
2004-11-30 |
2006-06-08 |
Nippon Chemiphar Co., Ltd. |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
CN102633730A
(zh)
|
2004-12-03 |
2012-08-15 |
先灵公司 |
作为cb1拮抗剂的取代哌嗪
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
US8148412B2
(en)
|
2004-12-03 |
2012-04-03 |
Novo Nordisk A/S |
Heteroaromatic glucokinase activators
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
US7795283B2
(en)
|
2004-12-14 |
2010-09-14 |
Astrazeneca Ab |
Oxadiazole derivative as DGAT inhibitors
|
WO2006065826A2
(en)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Process to chiral beta amino acid derivatives by asymmetric hydrogenation
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
WO2006066109A2
(en)
|
2004-12-17 |
2006-06-22 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
KR20070090192A
(ko)
|
2004-12-18 |
2007-09-05 |
바이엘 헬스케어 아게 |
(5s)-3-[(s)-플루오로(4-트리플루오로메틸페닐)메틸]-5,6,7,8-테트라히드로퀴놀린-5-올 유도체 및 이의 cetp억제제로서의 용도
|
JP2006176443A
(ja)
|
2004-12-22 |
2006-07-06 |
Shionogi & Co Ltd |
メラニン凝集ホルモン受容体アンタゴニスト
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
JP2008525404A
(ja)
|
2004-12-23 |
2008-07-17 |
アストラゼネカ アクチボラグ |
治療剤
|
US20080319019A1
(en)
|
2004-12-23 |
2008-12-25 |
Leifeng Cheng |
Therapeutic Agents
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
US8193359B2
(en)
|
2004-12-24 |
2012-06-05 |
Prosidion Limited |
G-protein coupled receptor agonists
|
BRPI0518651A2
(pt)
|
2004-12-24 |
2008-12-02 |
Dainippon Sumitomo Pharma |
composto, uma prà-droga do mesmo, ou um sal do composto ou prà-droga farmaceuticamente aceitÁvel, composiÇço farmacÊutica, inibidor de dipeptidil peptidase iv, uso de um composto, uma prà-droga do mesmo ou um sal do composto ou prà-droga farmaceuticamente aceitÁvel, e, mÉtodo para tratar diabetes
|
CA2591922A1
(en)
|
2004-12-24 |
2006-06-29 |
Prosidion Limited |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
EP1836166B1
(en)
|
2004-12-27 |
2009-06-17 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
DK1848430T3
(da)
|
2004-12-31 |
2017-11-06 |
Dr Reddys Laboratories Ltd |
Nye benzylamin-derivativer som cetp-inhibitors
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
ATE555081T1
(de)
|
2005-01-05 |
2012-05-15 |
Abbott Lab |
Adamantyl-derivate als inhibitoren des 11-beta- hydroxysteroid-dehydrogenase-1-enzyms
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
WO2006073167A1
(ja)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
CA2594684C
(en)
|
2005-01-18 |
2010-11-09 |
F. Hoffmann-La Roche Ag |
Morpholines as 5ht2c agonists
|
JP5094412B2
(ja)
|
2005-01-19 |
2012-12-12 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病治療用又は予防用のジペプチジルペプチダーゼ−iv阻害剤としての二環系ピリミジン
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
WO2006082952A1
(ja)
|
2005-02-01 |
2006-08-10 |
Takeda Pharmaceutical Company Limited |
アミド化合物
|
CA2595789A1
(en)
|
2005-02-03 |
2006-08-10 |
Irm Llc |
Compounds and compositions as ppar modulators
|
WO2006086562A2
(en)
|
2005-02-09 |
2006-08-17 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
DE602006019825D1
(de)
|
2005-02-15 |
2011-03-10 |
Kissei Pharmaceutical |
1-substituierte-7-(b-d-glycopyranosyloxy)(aza)indolverbindung und pharmazeutikum, das diese enthält
|
KR20070107000A
(ko)
|
2005-02-15 |
2007-11-06 |
노보 노르디스크 에이/에스 |
3,4-디히드로-1h-이소퀴놀린-2-카르복실산5-아미노피리딘-2-일 에스테르
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
AR055563A1
(es)
|
2005-02-25 |
2007-08-22 |
Takeda Pharmaceutical |
Compuestos de piridil acido acetico, agente farmaceutico y utilizacion del compuesto para preparar dicho agente
|
US20060229250A1
(en)
|
2005-03-09 |
2006-10-12 |
Jian Zhang |
Ghrelin associated peptide and its uses
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
WO2006102674A2
(en)
|
2005-03-24 |
2006-09-28 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
WO2006104030A1
(ja)
|
2005-03-25 |
2006-10-05 |
Daiichi Sankyo Company, Limited |
チアゾール化合物
|
BRPI0609268A2
(pt)
|
2005-03-31 |
2010-03-09 |
Pfizer Prod Inc |
derivados de ciclopentapiridina e tetraidroquinolina
|
CA2602234C
(en)
|
2005-04-01 |
2014-01-14 |
Eli Lilly And Company |
Histamine h3 receptor agents, preparation and therapeutic uses
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
PL1868999T3
(pl)
|
2005-04-06 |
2009-12-31 |
Hoffmann La Roche |
Pochodne pirydyno-3-karboksyamidu jako odwrotni agoniści CB1
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
US20090054423A1
(en)
|
2005-04-13 |
2009-02-26 |
Imbriglio Jason E |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
EP1874787B1
(en)
|
2005-04-15 |
2009-12-30 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
AR053712A1
(es)
|
2005-04-18 |
2007-05-16 |
Neurogen Corp |
Heteroarilos sustituidos, antagonistas de cb1 (receptor 1 canabinoide)
|
MX2007013049A
(es)
|
2005-04-19 |
2008-01-11 |
Bayer Pharmaceuticals Corp |
Preparacion y uso de derivados de aril alquil acido para el tratamiento de la obesidad.
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
EP1874779A1
(en)
|
2005-04-20 |
2008-01-09 |
Pfizer Products Inc. |
Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
|
CA2605778A1
(en)
|
2005-04-20 |
2006-10-26 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
US20080194494A1
(en)
|
2005-04-26 |
2008-08-14 |
Microbia, Inc. |
4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
|
WO2006118320A1
(ja)
|
2005-04-28 |
2006-11-09 |
Takeda Pharmaceutical Company Limited |
チエノピリミドン化合物
|
US20090131395A1
(en)
|
2005-05-05 |
2009-05-21 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
JP2008539735A
(ja)
|
2005-05-06 |
2008-11-20 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
グルカゴン様ペプチド1(glp−1)受容体アンタゴニストおよびそれらの薬理学的使用方法
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
EP1879860A2
(en)
|
2005-05-10 |
2008-01-23 |
Microbia Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
CN101171231A
(zh)
|
2005-05-10 |
2008-04-30 |
霍夫曼-拉罗奇有限公司 |
二酰基甘油酰基转移酶抑制剂
|
EP1885703A4
(en)
|
2005-05-11 |
2009-09-02 |
Microbia Inc |
METHODS FOR PRODUCING 4-BIPHENYLYLAZETIDIN-2-ONE PHENOLIC DERIVATIVES
|
US8183340B2
(en)
|
2005-05-13 |
2012-05-22 |
Eli Lilly And Company |
GLP-1 pegylated compounds
|
BRPI0610133A2
(pt)
|
2005-05-17 |
2010-06-01 |
Schering Corp |
heterociclos como agonistas de receptor de ácido nicotìnico para o tratamento de dislipidemia
|
WO2007046867A2
(en)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Piperidine derivatives and their uses as therapeutic agents
|
WO2007044085A2
(en)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Heteroaryl compounds and their uses as therapeutic agents
|
WO2007046868A2
(en)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Thiazolidine derivatives and their uses as therapeutic agents
|
KR20080025077A
(ko)
|
2005-05-25 |
2008-03-19 |
마이크로비아 인코포레이티드 |
4-(비페닐일)아제티딘-2-온 포스폰산의 제조방법
|
CN101500573A
(zh)
|
2005-05-25 |
2009-08-05 |
默克公司 |
用于糖尿病治疗或者预防的作为二肽基肽酶-ⅳ抑制剂的氨基环己烷
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
KR20080011677A
(ko)
|
2005-05-31 |
2008-02-05 |
아스트라제네카 아베 |
신규 mchr1 길항제 및 그의 mchr1 매개된 상태 및장애의 치료를 위한 용도
|
WO2006132436A1
(ja)
|
2005-06-08 |
2006-12-14 |
Japan Tobacco Inc. |
複素環化合物
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
MX2007014811A
(es)
|
2005-06-10 |
2008-02-14 |
Boehringer Ingelheim Int |
Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
|
CA2610188A1
(en)
|
2005-06-11 |
2006-12-21 |
Astrazeneca Ab |
Oxadiazole derivatives as dgat inhibitors
|
JP2008543837A
(ja)
|
2005-06-15 |
2008-12-04 |
メルク エンド カムパニー インコーポレーテッド |
抗高コレステロール血症化合物
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
ATE449094T1
(de)
|
2005-06-16 |
2009-12-15 |
Pfizer |
N-(pyridin-2-yl)sulfonamidderivate
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
WO2006133926A1
(en)
|
2005-06-17 |
2006-12-21 |
Carex Sa |
Pyrazole derivates as cannabinoid receptor modulators
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
CN101203502A
(zh)
|
2005-06-22 |
2008-06-18 |
霍夫曼-拉罗奇有限公司 |
(6-氟-苯并[1,3]间二氧杂环戊烯基)-吗啉-4-基-甲酮和它们作为cb1配体的用途
|
MY148538A
(en)
|
2005-06-22 |
2013-04-30 |
Astrazeneca Ab |
Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
|
WO2007001939A1
(en)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
|
WO2007000445A1
(en)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
AU2006264651A1
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
G-protein coupled receptor agonists
|
JP5114395B2
(ja)
|
2005-06-30 |
2013-01-09 |
プロシディオン・リミテッド |
Gpcrアゴニスト
|
GB0513692D0
(en)
|
2005-07-04 |
2005-08-10 |
Karobio Ab |
Novel pharmaceutical compositions
|
KR100979582B1
(ko)
|
2005-07-05 |
2010-09-01 |
에프. 호프만-라 로슈 아게 |
피리다진 유도체
|
WO2007007688A1
(ja)
|
2005-07-08 |
2007-01-18 |
Mochida Pharmaceutical Co., Ltd. |
3,5-ジアミノ-1,2,4-トリアゾール誘導体
|
KR20080024211A
(ko)
|
2005-07-08 |
2008-03-17 |
노보 노르디스크 에이/에스 |
디시클로알킬 우레아 글루코키나제 활성제
|
US20110053910A1
(en)
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
TWI359149B
(en)
|
2005-07-11 |
2012-03-01 |
Mitsubishi Tanabe Pharma Corp |
An oxime derivative and preparations thereof
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
EP1905769B1
(en)
|
2005-07-13 |
2017-03-29 |
Msd K.K. |
Heterocycle-substituted benzimidazole derivative
|
MX2008000255A
(es)
|
2005-07-14 |
2008-04-02 |
Novo Nordisk As |
Activadores de urea glucocinasa.
|
ES2326952B1
(es)
|
2005-07-15 |
2010-05-28 |
Laboratorios Del Dr. Esteve, S.A. |
Hidratos de (rac) -n-piperidinil-5-(4-clorofenil)-1-(2,4-diclorofenil)4,5-dihidro-1h-pirazol-3-carboxamida.
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
EP1757587A1
(en)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazoline compounds, their preparation and use as medicaments
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
KR20080031414A
(ko)
|
2005-07-18 |
2008-04-08 |
노보 노르디스크 에이/에스 |
비만치료에 사용하기 위한 신규 펩티드
|
AU2006270145B2
(en)
|
2005-07-19 |
2011-04-14 |
Msd K.K. |
Spirochromanone derivatives as acetyl coenzyme a carboxylase (ACC) inhibitors
|
JP2009501733A
(ja)
|
2005-07-20 |
2009-01-22 |
メルク フロスト カナダ リミテツド |
ステアロイルコエンザイムaデルタ−9デサチュラーゼの阻害剤としてのヘテロ芳香族化合物
|
DE602006007012D1
(de)
|
2005-07-20 |
2009-07-09 |
Lilly Co Eli |
Pyridinderivate als dipeptedyl-peptidase-hemmer
|
DE602006016821D1
(de)
|
2005-07-21 |
2010-10-21 |
Hoffmann La Roche |
Pyridazinonderivate als schilddrüsenhormon-rezeptoragonisten
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
KR100962723B1
(ko)
|
2005-07-21 |
2010-06-09 |
에프. 호프만-라 로슈 아게 |
단백질 티로신 포스파타제1b 억제제로서의피리도[2,3-d]피리미딘-2,4-다이아민 화합물
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
FR2889189A1
(fr)
|
2005-07-28 |
2007-02-02 |
Cerep Sa |
Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1
|
WO2007017126A2
(en)
|
2005-07-29 |
2007-02-15 |
Laboratorios Del Dr. Esteve, S.A. |
POLYMORPH OF N-PIPERIDINYL-5- (4-CHLOROPHENYL) -1- (2, 4-DICHLOROPHENYL) -4, 5-DIHYDRO-lH-PYRAZOLE- 3 -CARBOXAMIDE AND ITS USE AS A CAMNABINOID RECEPTOR MODULATOR
|
US8153694B2
(en)
|
2005-07-29 |
2012-04-10 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
ES2326357B1
(es)
|
2005-07-29 |
2010-04-21 |
Laboratorios Del Dr. Esteve, S.A. |
Fase amorfa de una pirazolina sustituida, su preparacion y su uso como medicamento.
|
EP1912634A4
(en)
|
2005-07-29 |
2010-06-09 |
Bayer Healthcare Llc |
PREPARATION AND USE OF BIPHENYL AMINOACIDAL DERIVATIVES TO TREAT OBESITY
|
EP1911753A1
(en)
|
2005-07-29 |
2008-04-16 |
Takeda Pharmaceutical Company Limited |
Spiro-cyclic compound
|
WO2007016460A2
(en)
|
2005-07-29 |
2007-02-08 |
Mayo Foundation For Medical Education And Research |
Skin pressure reduction by partial magnetic levitation
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
JP2009506987A
(ja)
|
2005-08-02 |
2009-02-19 |
ニューロゲン コーポレイション |
ジピペラジニルケトンおよび関連する類似体
|
EP1912968A1
(en)
|
2005-08-04 |
2008-04-23 |
Pfizer Limited |
Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
US20080306087A1
(en)
|
2005-08-08 |
2008-12-11 |
Astrazeneca Ab |
Therapeutic Agents
|
WO2007017649A1
(en)
|
2005-08-09 |
2007-02-15 |
Astrazeneca Ab |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
CA2618112A1
(en)
|
2005-08-10 |
2007-02-15 |
Banyu Pharmaceutical Co., Ltd. |
Pyridone compound
|
JP2009504592A
(ja)
|
2005-08-10 |
2009-02-05 |
スミスクライン・ビーチャム・コーポレイション |
選択的hm74aアゴニストとしてのキサンチン誘導体
|
WO2007020502A2
(en)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Cannabinoid receptor ligands and uses thereof
|
KR100962827B1
(ko)
|
2005-08-18 |
2010-06-10 |
에프. 호프만-라 로슈 아게 |
H3 수용체 조절제로서 유용한 티아졸릴 피페리딘 유도체
|
AU2006282260A1
(en)
|
2005-08-24 |
2007-03-01 |
Msd K.K. |
Phenylpyridone derivative
|
WO2007026215A1
(en)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
|
CA2620570A1
(en)
|
2005-08-29 |
2007-03-08 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
BRPI0615236A2
(pt)
|
2005-08-31 |
2011-05-10 |
Astellas Pharma Inc |
derivado de tiazol
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(en)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
EP1931633A2
(en)
|
2005-09-05 |
2008-06-18 |
Ranbaxy Laboratories Limited |
Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors
|
US20090264426A1
(en)
|
2005-09-07 |
2009-10-22 |
Shunji Sakuraba |
Bicyclic aromatic substituted pyridone derivative
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
AU2006291234A1
(en)
|
2005-09-14 |
2007-03-22 |
Amgen Inc. |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
US20090105263A1
(en)
|
2005-09-16 |
2009-04-23 |
Peter William Rodney Caulkett |
Heterobicyclic compounds as glucokinase activators
|
ES2326391T3
(es)
|
2005-09-16 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo.
|
AU2005337101A1
(en)
|
2005-09-21 |
2007-04-12 |
7Tm Pharma A/S |
Y2 selective receptor agonists for therapeutic interventions
|
BRPI0520563A2
(pt)
|
2005-09-21 |
2009-05-19 |
7Tm Pharma As |
agonistas de receptores y4 seletivos para intervenções terapêuticas
|
GB0519294D0
(en)
|
2005-09-21 |
2005-11-02 |
Karobio Ab |
Compounds
|
WO2007038138A2
(en)
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
EA200800889A1
(ru)
|
2005-09-23 |
2008-12-30 |
Янссен Фармацевтика, Н. В. |
Гексагидроциклооктилпиразольные каннабиноидные модуляторы
|
WO2007038045A1
(en)
|
2005-09-23 |
2007-04-05 |
Janssen Pharmaceutica, N.V. |
Tetrahydro-indazolyl cannabinoid modulators
|
JP5183479B2
(ja)
|
2005-09-29 |
2013-04-17 |
サノフイ |
フェニル基を有するフェニル−[1,2,4]−オキサジアゾール−5−オン誘導体、その製造方法、及び医薬品としてのその使用
|
BRPI0616463A2
(pt)
|
2005-09-29 |
2011-06-21 |
Merck & Co Inc |
composto, composição farmacêutica, e, uso de um composto
|
JP2007091649A
(ja)
|
2005-09-29 |
2007-04-12 |
Taisho Pharmaceut Co Ltd |
ピリミジン誘導体及びその使用に関連する治療方法
|
ATE429428T1
(de)
|
2005-09-30 |
2009-05-15 |
Hoffmann La Roche |
Indanderivate als antagonisten des mch-rezeptors
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
EP1942904A4
(en)
|
2005-09-30 |
2009-11-18 |
Merck & Co Inc |
CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
|
US20100160306A1
(en)
|
2005-09-30 |
2010-06-24 |
Bakshi Raman K |
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
JP4990783B2
(ja)
|
2005-09-30 |
2012-08-01 |
Msd株式会社 |
2−ヘテロアリール置換インドール誘導体
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
FR2891829A1
(fr)
|
2005-10-12 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de la 4-amino-quinazoline, leur preparation et leur application en therapeutique
|
FR2891828B1
(fr)
|
2005-10-12 |
2007-12-21 |
Sanofi Aventis Sa |
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
FR2891825B1
(fr)
|
2005-10-12 |
2007-12-14 |
Sanofi Aventis Sa |
Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
US20070105819A1
(en)
|
2005-10-17 |
2007-05-10 |
Roger Olsson |
CB-1 modulating compounds and their use
|
CA2625871C
(en)
|
2005-10-20 |
2014-07-08 |
Merck & Co., Inc. |
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
WO2007046548A1
(en)
|
2005-10-21 |
2007-04-26 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists
|
US8618115B2
(en)
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
CN101296906A
(zh)
|
2005-10-26 |
2008-10-29 |
贝林格尔·英格海姆国际有限公司 |
具有mch拮抗活性的(杂)芳基化合物及包含这些化合物的药物
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
DE102005052101A1
(de)
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
CA2627307A1
(en)
|
2005-11-01 |
2007-05-10 |
Transtech Pharma, Inc. |
Pharmaceutical use of substituted amides
|
WO2007053765A2
(en)
|
2005-11-01 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
|
EP1948652B1
(en)
|
2005-11-01 |
2011-08-24 |
Array Biopharma, Inc. |
Glucokinase activators
|
CA2627306A1
(en)
|
2005-11-01 |
2007-05-10 |
Transtech Pharma, Inc. |
Pharmaceutical use of substituted amides
|
BRPI0618062A2
(pt)
|
2005-11-03 |
2011-08-16 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
|
EP1948645A1
(en)
|
2005-11-03 |
2008-07-30 |
Prosidion Limited |
Tricyclo substituted amides
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
CA2628856A1
(en)
|
2005-11-08 |
2007-05-18 |
Jordi Frigola-Constansa |
Indene derivatives, their preparation and use as medicaments
|
US20070114078A1
(en)
|
2005-11-09 |
2007-05-24 |
Ososanya Esther T |
Super hybrid and enhanced electric cars
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|